$2.26
0.0050.22%
Últ. Act.: Oct 21, 8:59 AM
$2.18
-0.075-3.33%
Eledon Pharmaceuticals (ELDN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.16 | $-0.23 | $-0.20 | $-0.24 |
| Actual | $-0.27 | $-0.33 | $-0.10 | $-0.21 |
| Surprise | -68.8% | -43.5% | +50.0% | +12.5% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.19 | $-0.16 |
| Revenue | ||
| Consensus | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-0.27 | $-0.16 | -68.8 % |
| Q1 | May 13, 2026 | $-0.33 | $-0.23 | -43.5 % |
| Q4 | Mar 19, 2026 | $-0.10 | $-0.20 | 50.0 % |
| Q3 | Nov 14, 2025 | $-0.21 | $-0.24 | 12.5 % |